GlaxoSmtihKline
GSK to acquire oncology biotech Tesaro for $5.1 billion
December 3, 2018Sales and Marketing GSK, GlaxoSmtihKline, Tesaro, acquisition, oncology, pharma
GlaxoSmithKline is set to acquire US-based oncology biotech Tesaro after both companies signed a definitive agreement with an aggregate cash …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
